Due to a lack of resources and personnel, the FDA has delayed until October its decision on lifting a clinical hold on ALS ...

Australia’s Neurizon Therapeutics, a biotech advancing innovative treatments for neurodegenerative diseases, has reported positive top-line results from the Open-Label Extension (OLE) study of its ...

Robin Leaper lost her voice to ALS. Artificial Intelligence has given her back the ability to speak with her own voice.

Neurizon Therapeutics’ disease-modifying drug NUZ-001 has been shown to be safe and effective over 2.5 years of dosing in ...

A physical fitness challenge named the “Pete and Bobby Challenge” was held on the 19th at a massive gym facility in the U.S.

Family, friends and colleagues braved the heat early Friday evening to pay respect to the late Brent McGee, the former ...

MTPA's oral therapy Radicava (edaravone) has shown decreased functional decline and improved survival in long-term ALS trials ...

Summary: A new study has uncovered why some motor neurons resist degeneration in ALS while others succumb. Researchers found ...

Jodi O’Donnell-Ames founded Hope Loves Company to provide support, resources, and community to children affected by ALS.

Since 2023, the Inflation Reduction Act (IRA) has capped the cost of insulin for Medicare beneficiaries at $35 per month.

Hear the difference between Sarah's old robotic voice and her new AI-generated one "After such a long time, I couldn't really ...

Neurizon Therapeutics has reported positive topline results from an open-label extension (OLE) study of its lead candidate ...